Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.
|
September 20, 2009
|
September 4, 2009
|
May 20, 2009
|
April 5, 2009
|
|
March 9, 2009
|
February 25, 2009
|
August 27, 2008
|
August 15, 2008
|